Osimertinib is a third-generation EGFR-TKI for treatment of EGFR-mutated NSCLC, targeting Ex19Del mutation or L858R mutation, has central nervous system (CNS) penetrability.,
Sale!
Lucius
Replica Osimertinib EGFR-TKI CNS-Active NSCLC Therapy
Original price was: $698.00.$539.00Current price is: $539.00.
Osimertinib is a third-generation EGFR-TKI for treatment of EGFR-mutated NSCLC, targeting Ex19Del mutation or L858R mutation, has central nervous system (CNS) penetrability.,